Incerti D[au] - Search Results

Year	Number of Results
2017	3
2018	2
2019	6
2020	4
2021	4
2022	5
2023	2

1

Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases.

Incerti D, Xu XM, Chou JW, Gonzaludo N, Belmont JW, Schroeder BE. Incerti D, et al. Genet Med. 2022 Jan;24(1):109-118. doi: 10.1016/j.gim.2021.08.015. Epub 2021 Nov 30. Genet Med. 2022. PMID: 34906478 Free article. Review.

2

The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis.

Incerti D, Hernandez EJM, Tkacz J, Jansen JP, Collier D, Gharaibeh M, Moore-Schiltz L, Stolshek BS. Incerti D, et al. J Manag Care Spec Pharm. 2020 Oct;26(10):1236-1242. doi: 10.18553/jmcp.2020.26.10.1236. J Manag Care Spec Pharm. 2020. PMID: 32996384

3

Penalized regression for left-truncated and right-censored survival data.

McGough SF, Incerti D, Lyalina S, Copping R, Narasimhan B, Tibshirani R. McGough SF, et al. Among authors: incerti d. Stat Med. 2021 Nov 10;40(25):5487-5500. doi: 10.1002/sim.9136. Epub 2021 Jul 24. Stat Med. 2021. PMID: 34302373 Free PMC article.

4

Toward Relevant and Credible Cost-Effectiveness Analyses for Value Assessment in the Decentralized U.S. Health Care System.

Jansen JP, Incerti D, Curtis JR. Jansen JP, et al. Among authors: incerti d. J Manag Care Spec Pharm. 2019 May;25(5):518-521. doi: 10.18553/jmcp.2019.25.5.518. J Manag Care Spec Pharm. 2019. PMID: 31039069

5

Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer.

Huepenbecker SP, Wright JD, Downer MK, Incerti D, Luhn P, Dolado I, Bastiere-Truchot L, Lin YG, Chan JK, Meyer LA. Huepenbecker SP, et al. Among authors: incerti d. Obstet Gynecol. 2022 Nov 1;140(5):758-767. doi: 10.1097/AOG.0000000000004958. Epub 2022 Oct 5. Obstet Gynecol. 2022. PMID: 36201776

6

Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19.

Skarbinski J, Liu L, Hong V, Amsden LB, Fireman BH, Yau VM, Incerti D, Qian L, Fischer H, Ackerson BK, Shaw SF, Tartof SY. Skarbinski J, et al. Among authors: incerti d. BMJ Open. 2022 Oct 31;12(10):e060358. doi: 10.1136/bmjopen-2021-060358. BMJ Open. 2022. PMID: 36316080 Free PMC article.

7

An empirical investigation of time-varying cost-effectiveness across the product life cycle.

Stevens W, Incerti D, Peneva D, Shrestha A, Smith G, Ramaswamy K. Stevens W, et al. Among authors: incerti d. Health Econ. 2020 May;29(5):580-590. doi: 10.1002/hec.4004. Epub 2020 Feb 21. Health Econ. 2020. PMID: 32083778

8

R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment.

Incerti D, Thom H, Baio G, Jansen JP. Incerti D, et al. Value Health. 2019 May;22(5):575-579. doi: 10.1016/j.jval.2019.01.003. Value Health. 2019. PMID: 31104737 Free article.

9

The economic burden of kidney graft failure in the United States.

Sussell J, Silverstein AR, Goutam P, Incerti D, Kee R, Chen CX, Batty DS Jr, Jansen JP, Kasiske BL. Sussell J, et al. Among authors: incerti d. Am J Transplant. 2020 May;20(5):1323-1333. doi: 10.1111/ajt.15750. Epub 2020 Feb 4. Am J Transplant. 2020. PMID: 32020739 Free article.

10

Short-term costs of preeclampsia to the United States health care system.

Stevens W, Shih T, Incerti D, Ton TGN, Lee HC, Peneva D, Macones GA, Sibai BM, Jena AB. Stevens W, et al. Among authors: incerti d. Am J Obstet Gynecol. 2017 Sep;217(3):237-248.e16. doi: 10.1016/j.ajog.2017.04.032. Epub 2017 Jul 11. Am J Obstet Gynecol. 2017. PMID: 28708975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results